Is PSA Still the Best Predictor for Biochemical Recurrence after Radical Prostatectomy in High-Risk Prostate Cancer?

Akan, Serkan; Güner, Numan Dogu; Ediz, Caner; Sahin, Aytaç; Verit, Ayhan

Akan, Serkan; Güner, Numan Dogu; Ediz, Caner; Sahin, Aytaç; Verit, Ayhan.

Afiliação

Akan S; Department of Urology, University of Health Sciences, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey.
Güner ND; Department of Urology, University of Health Sciences, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey.
Ediz C; Department of Urology, University of Health Sciences, Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey.
Sahin A; Department of Urology, University of Health Sciences, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey.
Verit A; Department of Urology, University of Health Sciences, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey.

J Invest Surg ; 35(10): 1733-1738, 2022 Oct.

Article em En | MEDLINE | ID: mdl-35876092

Assuntos

Antígeno Prostático Específico; Neoplasias da Próstata; Humanos; Masculino; Recidiva Local de Neoplasia/diagnóstico; Recidiva Local de Neoplasia/epidemiologia; Prostatectomia/métodos; Neoplasias da Próstata/diagnóstico; Neoplasias da Próstata/cirurgia; Estudos Retrospectivos

Palavras-chave

Biochemical recurrence; biochemistry; cancer; high-risk; prostate cancer; prostate specific antigen; radical prostatectomy; urology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antígeno Prostático Específico Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google